Professor Ulrich Steidl describes research as “a team sport”
Ulrich Steidl discusses his work as an experimental haematologist in MDS and AML.
- Acute myeloid leukaemia
- Myelodysplastic syndromes
- Research
Ulrich Steidl discusses his work as an experimental haematologist in MDS and AML.
Veteran traveller Bryan Mitchell, get treatment for his MDS as he journeys from country to country… until COVID-19 put a stop to his travels.
When someone with MDS is treated with azacitidine (Vidaza®), it takes six months to find out if they are responding to the drug. Dr Unnikrishnan is working to change that.
For almost eight years, this has been Brian Merrick’s greeting when entering the treatment room in Melbourne for his monthly round of azacitidine (Vidaza®) injections on a clinical trial.
Louise thought it was her busy job that was making her tired, when she received a shock MDS diagnosis.
Professor Ricky Johnstone hopes to find new research treatments for B-cell lymphomas.
From current treatments to living with the disease, Dr Melita Kenealy covers the basics of MDS.
Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.